Trial Partnerships GAP’s global, trial-ready platform and mission to shorten trial cycle times position it as an attractive partner for pharma and biotech pursuing faster Alzheimer’s and Parkinson’s trials. Its GAP-Net network and certified high-performance sites provide a plug‑and‑play ecosystem to shorten study start-up and improve recruitment quality.

Site Network Advantage GAP operates a growing network of certified clinical trial sites and well-characterized cohorts, enabling sponsors to run multi-site studies with standardized quality. This creates upsell opportunities for data management, patient recruitment, site performance analytics, and CRO integration services.

Strategic Alliances Recent collaborations with Siemens Healthineers, Circular Genomics, and Spear Bio demonstrate GAP’s openness to ecosystem partnerships. Use cases include joint trials, shared pipelines, and co-marketing to tap partner audiences and accelerate sponsor value.

Global Funding With global reach and revenue scale, GAP can attract funding from governments, NGOs, and philanthropic organizations for large, diverse trials. Solutions to offer include global trial deployment packages, regulatory strategy support, and inclusive recruitment programs to sponsors.

Adaptive Trial Edge GAP’s adaptive proof-of-concept trial mechanism and Bio-Hermes studies show a proven platform for sponsor-driven innovation. Market GAP as turnkey adaptive trial infrastructure, enabling biomarker integration and real-world data to de-risk early-phase programs.